Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
RAG-01 in Non-Muscle Invasive Bladder Neoplasms: NCT07777848 Clinical Landscape Report 2026
11 September 2026
NCT07777848 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Pomalidomide in Diffuse Large B-Cell Lymphoma: NCT07749365 Clinical Landscape Report 2026
11 September 2026
NCT07749365 clinical landscape for Diffuse Large B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Esophageal Carcinoma: NCT07770100 Clinical Landscape Report 2026
11 September 2026
NCT07770100 clinical landscape for Esophageal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nemolizumab in Dermatitis, Atopic: NCT07762833 Clinical Landscape Report 2026
11 September 2026
NCT07762833 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Relapsing acute myeloid leukemia: NCT07766850 Clinical Landscape Report 2026
11 September 2026
NCT07766850 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Abatacept in Sickle Cell Trait: NCT07616154 Clinical Landscape Report 2026
11 September 2026
NCT07616154 clinical landscape for Sickle Cell Trait: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sitagliptin Phosphate in Parkinson Disease: NCT07804381 Clinical Landscape Report 2026
11 September 2026
NCT07804381 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Delandistrogene moxeparvovec in Muscular Dystrophy, Duchenne: NCT07542314 Clinical Landscape Report 2026
11 September 2026
NCT07542314 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MWN105 in Diabetes Mellitus, Type 2: NCT07803809 Clinical Landscape Report 2026
11 September 2026
NCT07803809 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Triple Negative Breast Cancer: NCT07783659 Clinical Landscape Report 2026
11 September 2026
NCT07783659 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mifamurtide in Osteosarcoma: NCT07787429 Clinical Landscape Report 2026
11 September 2026
NCT07787429 clinical landscape for Osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mepolizumab in Churg-Strauss Syndrome: NCT07343661 Clinical Landscape Report 2026
11 September 2026
NCT07343661 clinical landscape for Churg-Strauss Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.